Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Agelaki S, Syrigos K, Christophylakis C, Boukovinas J, Varthalitis J, Pavlakou G, Athanasiadis A, Kouroussis C, Vardakis N, Maltezakis G, Milaki G, Georgoulias V; Lung Cancer Subgroup, Hellenic Oncology Research Group. Agelaki S, et al. Among authors: kouroussis c. Oncology. 2004;66(3):192-6. doi: 10.1159/000077994. Oncology. 2004. PMID: 15218309 Clinical Trial.
Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Potamianou A, Androulakis N, Papakotoulas P, Toufexi H, Latoufis C, Kouroussis C, Christofilakis C, Xenidis N, Georgoulias V, Polyzos A. Potamianou A, et al. Among authors: kouroussis c. Oncology. 2005;69(4):348-53. doi: 10.1159/000089767. Epub 2005 Nov 16. Oncology. 2005. PMID: 16293974 Clinical Trial.
Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.
Georgoulias V, Ardavanis A, Agelidou A, Agelidou M, Chandrinos V, Tsaroucha E, Toumbis M, Kouroussis C, Syrigos K, Polyzos A, Samaras N, Papakotoulas P, Christofilakis C, Ziras N, Alegakis A. Georgoulias V, et al. Among authors: kouroussis c. J Clin Oncol. 2004 Jul 1;22(13):2602-9. doi: 10.1200/JCO.2004.11.004. J Clin Oncol. 2004. PMID: 15226327 Clinical Trial.
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Georgoulias V, Ardavanis A, Tsiafaki X, Agelidou A, Mixalopoulou P, Anagnostopoulou O, Ziotopoulos P, Toubis M, Syrigos K, Samaras N, Polyzos A, Christou A, Kakolyris S, Kouroussis C, Androulakis N, Samonis G, Chatzidaki D. Georgoulias V, et al. Among authors: kouroussis c. J Clin Oncol. 2005 May 1;23(13):2937-45. doi: 10.1200/JCO.2005.04.016. Epub 2005 Feb 22. J Clin Oncol. 2005. PMID: 15728228 Clinical Trial.
A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.
Agelaki S, Veslemes M, Syrigos K, Palamidas F, Polyzos A, Papakotoulas P, Kentepozidis N, Milaki G, Tzanakis N, Kouroussis C, Vamvakas L, Georgoulias V; Hellenic Oncology Research Group. Agelaki S, et al. Among authors: kouroussis c. Lung Cancer. 2004 Mar;43(3):329-33. doi: 10.1016/j.lungcan.2003.08.031. Lung Cancer. 2004. PMID: 15165092 Clinical Trial.
87 results